Amgen (AMGN) Financials
Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2025
Full Amgen financials for 1986 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Amgen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Mar-31 | 8,149 | 5,181 (63.6 %) | 1,178 (14.5 %) | 1,730 (21.2 %) | 1,178 | 3.20 |
| 2024-Dec-31 | 9,086 | 5,974 (65.7 %) | 2,311 (25.4 %) | 627 (6.9 %) | 2,926 | 1.16 |
| 2024-Sep-30 | 8,503 | 5,193 (61.1 %) | 2,047 (24.1 %) | 2,830 (33.3 %) | 5,288 | 5.22 |
| 2024-Jun-30 | 8,333 | 5,097 (61.2 %) | 1,854 (22.2 %) | 746 (9.0 %) | 3,254 | 1.38 |
| 2024-Mar-31 | 7,396 | 4,196 (56.7 %) | 940 (12.7 %) | -113 (-1.5 %) | 2,339 | -0.21 |
| 2023-Dec-31 | 8,196 | 5,084 (62.0 %) | 1,271 (15.5 %) | 767 (9.4 %) | 3,053 | 1.42 |
| 2023-Sep-30 | 6,903 | 5,097 (73.8 %) | 2,021 (29.3 %) | 1,730 (25.1 %) | 2,706 | 3.22 |
Full historical income statements for 1986 - 2025 is included in the
US Historical Financials dataset.
Amgen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Mar-31 | 89,367 | 83,160 | 57,381 | 6,207 | 8,810 |
| 2024-Dec-31 | 91,839 | 85,962 | 60,099 | 5,877 | 11,973 |
| 2024-Sep-30 | 90,883 | 83,356 | 60,398 | 7,527 | 9,011 |
| 2024-Jun-30 | 90,907 | 84,982 | 62,645 | 5,925 | 9,301 |
| 2024-Mar-31 | 92,980 | 87,958 | 64,020 | 5,022 | 9,708 |
| 2023-Dec-31 | 97,154 | 90,922 | 64,613 | 6,232 | 10,944 |
| 2023-Sep-30 | 90,534 | 82,878 | 60,468 | 7,656 | 34,741 |
Full historical balance sheet data for 1986 - 2025 is included in the
US Historical Financials dataset.
Amgen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Mar-31 | 1,391 | -447 | -4,107 | 980 |
| 2024-Dec-31 | 4,771 | -402 | -1,407 | 4,400 |
| 2024-Sep-30 | 3,571 | -210 | -3,651 | 3,314 |
| 2024-Jun-30 | 2,459 | -217 | -2,649 | 2,221 |
| 2024-Mar-31 | 689 | -217 | -1,708 | 459 |
| 2023-Dec-31 | 538 | -27,089 | 2,754 | 289 |
| 2023-Sep-30 | 2,760 | -262 | -2,005 | 2,760 |
Full historical cash flow data for 1986 - 2025 is included in the
US Historical Financials dataset.
Amgen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Mar-31 | 167,614 | 216,185 | 20.57 | 24.22 | 27.00 |
| 2024-Dec-31 | 140,880 | 189,006 | 15.51 | 56.17 | 23.97 |
| 2024-Sep-30 | 173,027 | 224,414 | 20.35 | 15.29 | 22.99 |
| 2024-Jun-30 | 167,012 | 220,356 | 20.04 | 55.97 | 28.19 |
| 2024-Mar-31 | 151,709 | 206,021 | 20.51 | -335.64 | 30.21 |
| 2023-Dec-31 | 154,091 | 207,760 | 18.80 | 50.23 | 24.73 |
| 2023-Sep-30 | 143,787 | 169,514 | 20.83 | 20.78 | 18.78 |
Full historical valuation and operating metrics for 1986 - 2025 are included in the
US Historical Financials dataset.